Sling Therapeutics hires new CCO
ANN ARBOR–Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease, announced the appointment of Ken Lock as …
Contract research organization expands executive team
CANTON TWP.–MMS Holdings, a contract research organization, announced an expansion of its leadership team with the appointment of Chris Schoonmaker as COO and Ashu Tandon as chief commercial officer. Both Schoonmaker and Tandon …
Millendo names chief commercial officer
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), the developer of new endocrine drugs, announced the promotion of Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo …
OptimizeRx adds ‘chief commercial officer’
ROCHESTER—Officials at OptimizeRx Corp. (NASDAQ: OPRX), a provider of digital health messaging in the pharmaceutical industry, announced the appointment of Stephen Silvestro to the new position of chief commercial officer. …